Deerfield, IL, US.
The Director, Health Economics and Outcomes Research will have the primary responsibility for identifying and conducting the health economics outcomes research activities required for the successful development of Lundbeck’s neuro-rare pipeline. The role has both US responsibilities and ex-US responsibilities. The activities include design and implementation of real-world evidence studies, assessment of patient reported outcomes, economic modelling and input into BD&L assessments. The Director will work closely with both US and Global teams (Medical Affairs, Commercial and Market Access) to ensure optimal and efficient collaboration on HEOR plan and deliverables.
ESSENTIAL FUNCTIONS:
- Leads the development of HEOR strategies for pipeline projects in close collaboration with clinical, medical, market access and marketing departments globally and in the US.
- Scans the US and ex-US payer environment (via industry meetings and conferences) in the rare-disease field and share relevant insights with the whole Value Evidence team.
- Provides HEOR input to BD&L assessments.
- Identify evidence gaps and potential solutions to address them.
- Design research initiatives to demonstrate the value of Lundbeck drug therapies.
- Prepare core deliverables (e.g. AMCP/Global value dossiers, early budget impact and cost-effectiveness models, burden of illness and unmet needs reports, etc.) to support US and Global pricing and reimbursement needs.
- Responsible for developing and maintaining and understanding of scientific and methodological developments for rare diseases.
REQUIRED EDUCATION, EXPERIENCE, and SKILLS:
- Combination of academic training and practical experience in outcomes research and health economics is required. This may consist of:
- Doctoral degree in a relevant discipline such as, but not limited to, health services research, health outcomes research, epidemiology, pharmacy administration, public health, economics, statistics or decision sciences, plus five (5) of practical experience.
- Or Master’s Degree in a related discipline (as noted above), plus eight (8) years of practical experience.
- Specific experience/knowledge about market access requirements for US and health technology assessment (HTA) markets.
- Experience in preparing a drug launch.
- Firm understanding and expertise in the field of Outcomes Research, Health Economics in drug development phase.
- Proven track record of leadership, strategic thinking and teamwork.
PREFERRED EDUCATION, EXPERIENCE, and SKILLS:
- Experience in the CNS therapeutic area and/or rare disease.
- EU HTA regulation knowledge.
TRAVEL:
- Willingness/Ability to travel up to 20% domestically and international travel may be required. #LI-LM1
The range displayed is specifically for those potential hires who will work or reside in the state of Illinois if selected for this role and may vary based on various factors such as the candidate’s qualifications, skills, competencies, and proficiency for the role. Salary Pay Range: $225,000 – $265,000 and eligibility for a 25% bonus target based on company and individual performance, and eligibility to participate in the company’s long-term incentive plan. Additional benefits for this position include flexible paid time off (PTO), health benefits to include Medical, Dental and Vision and company match 401k. Additional benefits information can be found on our site. Applications accepted on an ongoing basis.
This job ad will be unpublished on 03/03/2025.
This job is posted by Lundbeck.
This link brings you to the website of Lundbeck.
Please mention that you found the role via EuropeanHealthEconomics.com. Thank you and good luck!
